1. Home
  2. ROIV vs WIX Comparison

ROIV vs WIX Comparison

Compare ROIV & WIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ROIV
  • WIX
  • Stock Information
  • Founded
  • ROIV 2014
  • WIX 2006
  • Country
  • ROIV United Kingdom
  • WIX Israel
  • Employees
  • ROIV N/A
  • WIX N/A
  • Industry
  • ROIV Biotechnology: Pharmaceutical Preparations
  • WIX Computer Software: Programming Data Processing
  • Sector
  • ROIV Health Care
  • WIX Technology
  • Exchange
  • ROIV Nasdaq
  • WIX Nasdaq
  • Market Cap
  • ROIV 7.8B
  • WIX 9.2B
  • IPO Year
  • ROIV N/A
  • WIX 2013
  • Fundamental
  • Price
  • ROIV $10.99
  • WIX $164.29
  • Analyst Decision
  • ROIV Buy
  • WIX Strong Buy
  • Analyst Count
  • ROIV 4
  • WIX 18
  • Target Price
  • ROIV $17.50
  • WIX $226.94
  • AVG Volume (30 Days)
  • ROIV 7.2M
  • WIX 976.2K
  • Earning Date
  • ROIV 08-07-2025
  • WIX 08-06-2025
  • Dividend Yield
  • ROIV N/A
  • WIX N/A
  • EPS Growth
  • ROIV N/A
  • WIX 119.71
  • EPS
  • ROIV N/A
  • WIX 2.51
  • Revenue
  • ROIV $29,053,000.00
  • WIX $1,814,525,000.00
  • Revenue This Year
  • ROIV $2.64
  • WIX $13.94
  • Revenue Next Year
  • ROIV $378.09
  • WIX $12.71
  • P/E Ratio
  • ROIV N/A
  • WIX $65.33
  • Revenue Growth
  • ROIV N/A
  • WIX 12.89
  • 52 Week Low
  • ROIV $8.73
  • WIX $137.94
  • 52 Week High
  • ROIV $13.06
  • WIX $247.11
  • Technical
  • Relative Strength Index (RSI)
  • ROIV 44.89
  • WIX 58.04
  • Support Level
  • ROIV $10.83
  • WIX $155.04
  • Resistance Level
  • ROIV $11.82
  • WIX $164.37
  • Average True Range (ATR)
  • ROIV 0.32
  • WIX 4.75
  • MACD
  • ROIV -0.07
  • WIX 1.23
  • Stochastic Oscillator
  • ROIV 16.75
  • WIX 84.29

About ROIV Roivant Sciences Ltd.

Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.

About WIX Wix.com Ltd.

Wix.com is a software-as-a-service content management system platform that allows users to create, customize, and manage websites for themselves, or for clients. Wix is best known for its Wix Editor service for self-creators, but in recent years has invested heavily and introduced its Wix Studio offering for partners, who are agencies and developers. Wix also offers a range of business solutions such as payment services and marketing products.

Share on Social Networks: